Monday, 28 May 2018

You are here

No Arthroscopy Needed for Degenerative Knees and Meniscal Tears

The British Medical Journal has published a clinical practice guideline for the use of arthroscopic surgery for degenerative knee arthritis and meniscal tears, suggesting that many patients will not benefit from such surgery. (Citation source http://buff.ly/2pNhgug)

Reuters reports that globally, > 2 million people annually will have arthroscopic surgery for degenerative knees. These new guidelines recommend against for most patients with knee arthritis arthritis.

In the US the annual cost of arthroscopic knee surgery is nearly $3 billion, and although the risk of serious adverse events is low, its utility was questioned by an multidisciplinary panel who reviewed data from 13 randomized controlled trials.

In the end, the panel strongly recommended against arthroscopy based on a low probability (15%) of improving short-term pain and function that does not last for a year. This is in addition to the burden/pain experienced postoperatively and rare risk of serious adverse effects associated with knee arthroscopy. 

Experts suggest that  intraarticular corticosteroids, physical therapy and anti-inflammatory medications are as effective as surgery for degenerative meniscal tears,

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Restless Sleep and Inactivity Intertwined in OA

Adults with osteoarthritis (OA) of the knee who frequently experienced restless sleep were less likely to engage in potentially beneficial moderate-to-vigorous physical activity, analysis of data from the Osteoarthritis Initiative found.

FDA Approves Denosumab for Glucocorticoid-Induced Osteoporosis

Amgen announced that the U.S. Food and Drug Administration (FDA) has approved the use of Prolia® (denosumab) for the treatment of glucocorticoid-induced osteoporosis (GIOP) in men and women at high risk of fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.

Bisphosphonate Drug Holidays May Result in Fractures

A report in Endocrine Practice shows that drug holidays from bisphosphonates results in a 15% risk of fractures.  (Citation source: http://bit.ly/2FHbFwp)

USPSTF Recommendations on Vitamin D, Calcium Supplementation to Prevent Fractures

The U.S. Preventive Services Task Force (USPSTF) concludes current scientific evidence is insufficient regarding the use of vitamin D and calcium, alone or in combination, to prevent fractures in men and premenopausal women. The USPSTF recommends against daily supplementation with 400 IU or less of vitamin D and 1,000 mg or less of calcium to prevent fractures in postmenopausal women. Current scientific evidence is insufficient regarding the use of vitamin D and calcium at doses greater than 400 IU of vitamin D and greater than 1,000 mg of calcium in postmenopausal women.

Obesity Surgery Tames Knee OA Pain

Laparoscopic gastric band (LAGB) surgery was associated with significant decreases in knee pain from osteoarthritis (OA), with the greatest improvements seen among those whose body mass index (BMI) had the greatest decreases and among younger patients, researchers reported.